Personal information

Keywords

particle analytics, drug product developement

Activities

Collapse all

Employment (1)

AbbVie Deutschland GmbH and Co KG: Ludwigshafen, Rhineland-Platinate, DE

Senior Scientist (R&D)
Employment
Source: Self-asserted source
Harri Rahn

Works (3)

Elucidation of the Reversible Self-Association Interface of a Diabody–Interleukin Fusion Protein Using Hydrogen-Exchange Mass Spectrometry and In Silico Modeling

Molecular Pharmaceutics
2024-09-02 | Journal article
DOI: 10.1021/acs.molpharmaceut.4c00169
Contributors: Martin Eisinger; Harri Rahn; Yong Chen; Melissa Fernandes; Zhiyi Lin; Nikolai Hentze; Davide Tavella; Ehab M. Moussa
Source: check_circle
Crossref

The Strengths of Total Holographic Video Microscopy in Detecting Sub-Visible Protein Particles in Biopharmaceuticals: A Comparison to Flow Imaging and Resonant Mass Measurement

Journal of Pharmaceutical Sciences
2023-04 | Journal article
DOI: 10.1016/j.xphs.2022.12.023
Contributors: Harri Rahn; Merve Oeztuerk; Nikolai Hentze; Friederike Junge; Markus Hollmann
Source: check_circle
Crossref

Trafficking of JC virus-like particles across the blood–brain barrier

Nanoscale Advances
2021 | Journal article
DOI: 10.1039/d0na00879f
Part of ISSN: 2516-0230
Source: Self-asserted source
Harri Rahn
How many people are using ORCID?